World News: 11:00 GMT Friday 9th November 2018. [Mesoblast Limited via Globe Newswire via SPi World News]
NEW YORK and MELBOURNE Australia Nov 09 2018 GLOBE NEWSWIRE) -- Mesoblast Limited NasdaqMESO (ASX:MSB) will host a webcast to discuss the results of the Phase 2b trial evaluating its allogeneic mesenchymal precursor cell product candidate MPC-150...
Globe Newswire: 11:00 GMT Friday 9th November 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.